Education
About Us
Working with TipRanks
Follow Us
bioMerieux (FR:BIM)
:BIM
BIM Stock Chart & Stats
€107.10
€1.20(1.14%)
At close: 4:00 PM EST
€107.10
€1.20(1.14%)
Day’s Range― - ―
52-Week Range€96.90 - €128.30
Previous CloseN/A
Volume6.19K
Average Volume (3M)107.98K
Market Cap
€12.99B
Enterprise Value€14.09B
Total Cash (Recent Filing)€380.50M
Total Debt (Recent Filing)€506.40M
Price to Earnings (P/E)34.3
Beta0.54
Next Earnings
Mar 04, 2026EPS Estimate
2.06Next Dividend Ex-DateN/A
Dividend Yield0.82%
Share Statistics
EPS (TTM)1.35
Shares Outstanding118,361,220
10 Day Avg. Volume122,242
30 Day Avg. Volume107,982
Financial Highlights & Ratios
PEG Ratio1.34
Price to Book (P/B)2.90
Price to Sales (P/S)3.06
P/FCF Ratio37.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€121.67Price Target Upside13.60% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Guidance IncreaseFull-year guidance was uplifted from 6-8% to 8-10% organic sales growth.
Organic GrowthOrganic growth for the quarter was 10.3%, surpassing the consensus expectation of 8.4%.
Product LaunchesNew product launches like SPOTFIRE, VITEK, and VIDAS approvals are driving in-market traction.
Bears Say
Installed Base GrowthBIOFIRE installed base growth slowdown may be debated.
Product Segment PerformanceImmunoassays are still weighed down by the decrease in procalcitonin tests.
bioMerieux News
BIM FAQ
What was bioMerieux’s price range in the past 12 months?
bioMerieux lowest stock price was €96.90 and its highest was €128.30 in the past 12 months.
What is bioMerieux’s market cap?
bioMerieux’s market cap is €12.99B.
When is bioMerieux’s upcoming earnings report date?
bioMerieux’s upcoming earnings report date is Mar 04, 2026 which is in 68 days.
How were bioMerieux’s earnings last quarter?
bioMerieux released its earnings results on Sep 04, 2025. The company reported €1.35 earnings per share for the quarter, missing the consensus estimate of €2.165 by -€0.815.
Is bioMerieux overvalued?
According to Wall Street analysts bioMerieux’s price is currently Undervalued.
Does bioMerieux pay dividends?
bioMerieux pays a Annually dividend of €0.9 which represents an annual dividend yield of 0.82%. See more information on bioMerieux dividends here
What is bioMerieux’s EPS estimate?
bioMerieux’s EPS estimate is 2.06.
How many shares outstanding does bioMerieux have?
bioMerieux has 118,361,220 shares outstanding.
What happened to bioMerieux’s price movement after its last earnings report?
bioMerieux reported an EPS of €1.35 in its last earnings report, missing expectations of €2.165. Following the earnings report the stock price went down -1.866%.
Which hedge fund is a major shareholder of bioMerieux?
Currently, no hedge funds are holding shares in FR:BIM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
bioMerieux
bioMérieux (BIM) is a global leader in in vitro diagnostics, specializing in the development of innovative diagnostic solutions for medical and industrial applications. Founded in 1963 and headquartered in Marcy-l'Étoile, France, the company focuses on providing diagnostic tools to detect infectious diseases, monitor chronic conditions, and ensure food safety. Its core products include a range of assays, instruments, and software solutions that facilitate the rapid and accurate diagnosis of health conditions, contributing to improved patient care and safety.
BIM Stock 12 Month Forecast
Average Price Target
€121.67
▲(13.60% Upside)
Technical Analysis
Eurofins Scientific
―
Sartorius Stedim Biotech
―
Sanofi
―
Eurobio-Scientific SA
―
Biosynex SA
―
Options Prices
Currently, No data available
---